Figure 2.

Overall survival of cervical or head and neck cancer patients for one year following 7 weeks of testosterone or placebo treatment (no patient data was censored before 12 months).

Overall survival of cervical or head and neck cancer patients for one year following 7 weeks of testosterone or placebo treatment (no patient data was censored before 12 months).